NCT01792700View on ClinicalTrials.gov

Long-term Follow up Helicobacter Pylori Reinfection Rate After Second-Line Treatment: Bismuth-Containing Quadruple Therapy Versus Moxifloxacin-Based Triple Therapy

PHASE4CompletedINTERVENTIONAL

Enrollment

648

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions

Helicobacter Infections

Interventions

DRUG

esomeprazole

DRUG

tripotassium dicitrate bismuthate

DRUG

metronidazole

DRUG

tetracycline

DRUG

moxifloxacin

DRUG

amoxicillin

Trial Locations (1)

Unknown

Seoul National University Bundang Hospital, Seongnam-si

All Listed Sponsors

lead

Seoul National University Bundang Hospital

OTHER

NCT01792700 - Long-term Follow up Helicobacter Pylori Reinfection Rate After Second-Line Treatment: Bismuth-Containing Quadruple Therapy Versus Moxifloxacin-Based Triple Therapy | Biotech Hunter | Biotech Hunter